C3 - complement C3 Gene

Also Known as ASP; C3a; C3b; AHUS5; ARMD9; CPAMD1; HEL-S-62p

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 718

About C3

Cytogenetic location: 19p13.3 Genomic coordinates (GRCh38): 19:6,677,704-6,720,650 (from NCBI)

This gene has 28 transcripts (splice variants), 268 orthologues, 8 paralogues and is associated with 6 phenotypes. Biased expression in liver (RPKM 1676.7), gall bladder (RPKM 250.0) and 5 other tissues.

Summary

Complement component C3 plays a central role in the activation of Complement System. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]

C3 Products (2)

mRNA	Protein	Name
NM_000064.4	NP_000055.2	complement C3 preproprotein
NM_000064.4	NP_000055.2	complement C3 preproprotein

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables C5L2 anaphylatoxin chemotactic receptor binding	IDA IDA: Inferred from direct assay	15833747	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	7483825	GOA
enables receptor ligand activity	IDA IDA: Inferred from direct assay	21527715	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in B cell activation	IDA IDA: Inferred from direct assay	30107486	GOA
involved in complement activation	IMP IMP: Inferred from mutant phenotype	19302245	GOA
involved in positive regulation of D-glucose transmembrane transport	IDA IDA: Inferred from direct assay	9059512	GOA
involved in positive regulation of G protein-coupled receptor signaling pathway	IDA IDA: Inferred from direct assay	15833747	GOA
involved in positive regulation of apoptotic cell clearance	IMP IMP: Inferred from mutant phenotype	19302245	GOA
involved in positive regulation of lipid storage	IDA IDA: Inferred from direct assay	9555951	GOA
involved in positive regulation of protein phosphorylation	IDA IDA: Inferred from direct assay	15833747	GOA
involved in positive regulation of vascular endothelial growth factor production	IDA IDA: Inferred from direct assay	16452172	GOA
involved in regulation of triglyceride biosynthetic process	IDA IDA: Inferred from direct assay	10432298	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in extracellular space	IDA IDA: Inferred from direct assay	25645918	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C3 Protein Structure

A2M_N

A2M_N_2

ANATO

A2M

Thiol-ester_cl

A2M_comp

A2M_recep

NTR

0
300
600
900
1200
1500
1663 a.a.

Protein Preferred Names	Protein Names
complement C3	C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1

C3 Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	C3	P01024	KRTAP10-8	Homo sapiens	P60410	Validated Y2H	32296183
Intra	C3	P01024	KRTAP10-8	Homo sapiens	P60410	Y2H Prey Pooling	32296183
Intra	C3	P01024	KRTAP10-8	Homo sapiens	P60410	Y2H Array	32296183
Intra	C3	P01024	CFH	Homo sapiens	P08603	SPR	21317894
Intra	C3	P01024	CFH	Homo sapiens	P08603	ELISA	21979047
Intra	C3	P01024	CFH	Homo sapiens	P08603	Solid Phase Assay	21317894
Intra	C3	P01024	CFH	Homo sapiens	P08603	X-Ray Diffraction	21317894
Intra	C3	P01024	CFH	Homo sapiens	P08603	NMR	21317894
Intra	C3	P01024	CFHR4	Homo sapiens	Q92496-1	ELISA	22518841
Intra	C3	P01024	Q03591-PRO_0000005896	Homo sapiens	Q03591-PRO_0000005896	ELISA	27814381
Intra	C3	P01024	CD46	Homo sapiens	P15529	ELISA	23086448
Intra	C3	P01024	CD46	Homo sapiens	P15529	ELISA	18796626
Intra	C3	P01024	CR2	Homo sapiens	P20023	SPR	21527715
Intra	C3	P01024	CR2	Homo sapiens	P20023	X-Ray Diffraction	11387479
Intra	C3	P01024	CR2	Homo sapiens	P20023	X-Ray Diffraction	21527715
Intra	C3	P01024	CR2	Homo sapiens	P20023	ELISA	11387479
Intra	C3	P01024	GOLGA6L9	Homo sapiens	A6NEM1	Y2H Prey Pooling	32296183
Intra	C3	P01024	GOLGA6L9	Homo sapiens	A6NEM1	Y2H Array	32296183
Intra	C3	P01024	AGR2	Homo sapiens	O95994	Y2H Prey Pooling	32296183
Intra	C3	P01024	AGR2	Homo sapiens	O95994	Y2H Array	32296183
Intra	C3	P01024	PLEKHF2	Homo sapiens	Q9H8W4	Y2H Prey Pooling	32296183
Intra	C3	P01024	PLEKHF2	Homo sapiens	Q9H8W4	Validated Y2H	32296183
Intra	C3	P01024	PLEKHF2	Homo sapiens	Q9H8W4	Y2H Array	32296183
Intra	C3	P01024	EFEMP2	Homo sapiens	O95967	Y2H Prey Pooling	32296183
Intra	C3	P01024	EFEMP2	Homo sapiens	O95967	Y2H Array	32296183
Intra	C3	P01024	VSIG4	Homo sapiens	Q9Y279-1	SPR	16530040
Intra	C3	P01024	VSIG4	Homo sapiens	Q9Y279-1	FACS	16530040
Intra	C3	P01024	VSIG4	Homo sapiens	Q9Y279-1	ELISA	16530040
Intra	C3	P01024	VSIG4	Homo sapiens	Q9Y279-2	SPR	16530040
Intra	C3	P01024	VSIG4	Homo sapiens	Q9Y279-2	ELISA	16530040
Intra	C3	P01024	KRT31	Homo sapiens	Q15323	Validated Y2H	32296183
Intra	C3	P01024	KRT31	Homo sapiens	Q15323	Y2H Prey Pooling	32296183
Intra	C3	P01024	KRT31	Homo sapiens	Q15323	Y2H Array	32296183

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant C3 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P7862	Complement C3a Protein, Human	P01024 (S672-R748)	≥ 95%, as determined by reducing SDS-PAGE.

C3 Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P80577	C3 Antibody (YA575)	WB, IHC-P	Human
HY-P80577A	C3 Antibody (YA575)(PBS only)	WB, IHC-P	Human
HY-P83897	C3C Antibody (YA3594)	WB, IHC-P, ICC/IF, FC, ELISA	Human
HY-P83897A	C3C Antibody (YA3594)(PBS only)	WB, IHC-P, ICC/IF, FC, ELISA	Human

Related Diseases

Diseases	Alias
Hemolytic Uremic Syndrome, Atypical 5	AHUS5 Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 5 Atypical Hemolytic-Uremic Syndrome With C3 Anomaly Ahus 5 Ahus, Susceptibility To, 5 Hemolytic Uremic Syndrome Atypical 5 Atypical Hemolytic Uremic Syndrome With C3 Anomaly
Complement Component 3 Deficiency, Autosomal Recessive	C3 Deficiency C3D C3 Deficiency, Autosomal Recessive Complement Component 3 Deficiency C3 Deficiency Autosomal Recessive Complement Component 3 Deficiency Autosomal Recessive Immune System Diseases
Macular Degeneration, Age-Related, 9	Age Related Macular Degeneration 9 ARMD9 Macular Degeneration, Age-Related, 9, Susceptibility To Macular Degeneration, Age-Related, Type 9
Complement Component 3 Deficiency	C3 Deficiency
Atypical Hemolytic Uremic Syndrome With Complement Gene Abnormality	Atypical Hus With Complement Gene Abnormality Ahus With Complement Gene Abnormality
D-Minus Hemolytic Uremic Syndrome	Atypical Hus Atypical Hemolytic Uremic Syndrome Hus, Atypical Ahus
Hemolytic Uremic Syndrome, Atypical 1	Atypical Hemolytic-Uremic Syndrome Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1 Atypical Hemolytic Uremic Syndrome Hemolytic Uremic Syndrome, Atypical, Susceptibility To Ahus AHUS1 Hemolytic-Uremic Syndrome Ahus 1 Ahus, Susceptibility To, 1 Hemolytic Uremic Syndrome, Atypical Non-Shiga-Like Toxin-Associated Hus Non-Stx-Hus Nonenteropathic Hus Atypical Hus Shiga Toxin-Associated Hemolytic Uremic Syndrome D+ Hus Ehec-Hus Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli Hemolytic Uremic Syndrome With Diarrhea Stec-Hus Shiga-Like Toxin-Associated Hus Stx-Hus Typical Hus Typical Hemolytic Uremic Syndrome Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies Atypical Hus With Anti-Factor H Antibodies Ahus With Anti-Factor H Antibodies Ahus With Neutralizing Autoantibodies Against Factor H Hemolytic Uremic Syndrome Atypical 1 Atypical Hemolytic Uremic Syndrome With H Factor Anomaly D Hus Hemolytic-Uremic Syndrome Without Diarrhea Hemolytic-Uremic Syndrome, Atypical, Type 1 Hemolytic Uremic Syndrome, Typical
Membranoproliferative Glomerulonephritis	Mesangiocapillary Glomerulonephritis Dense Deposit Disease Membranoproliferative Glomerulonephritis Type 2 Primary Membranoproliferative Glomerulonephritis Mesangiocapillary Glomerulonephritis, Type Ii Glomerulonephritis, Membranoproliferative Chronic Glomerulonephritis, Lobular Lobular Glomerulonephritis Ddd Glomerulonephritis Membranoproliferative Type 2 Mpgn 2 Membranoproliferative Glomerulonephritis Type Ii Mesangiocapillary Glomerulonephritis Type 2 Mpgn Primary Mpgn Glomerulonephritis Membranoproliferative Membranoproliferative Glomerulonephritis, Type Ii
Genetic Atypical Hemolytic-Uremic Syndrome	Familial Atypical Hemolytic-Uremic Syndrome Familial Atypical Hemolytic Uremic Syndrome
Hemolytic-Uremic Syndrome	Hemolytic Uremic Syndrome Haemolytic-Uraemic Syndrome Hus Acute Renal Failure, Thrombocytopenia, And Microangiopathic Hemolytic Anemia Associated With Distorted Erythrocytes Typical Haemolytic Uraemic Syndrome Gasser Syndrome Hus - [Haemolytic Uraemic Syndrome]
Glomerulonephritis	Bright'S Disease
Arteriolosclerosis
Complement Deficiency	Complement Deficiency Disease Hereditary Complement Deficiency Diseases
Retinal Drusen
Hemoglobinuria
Diffuse Glomerulonephritis	Glomerulonephritis Diffuse
Afibrinogenemia, Congenital	Congenital Afibrinogenemia Afibrinogenemia Factor I Deficiency Familial Afibrinogenemia Hypofibrinogenemia, Congenital Fibrinogen Deficiency Afibrinogenemia Congenital CAFBN Congenital Hypofibrinogenemia Hypofibrinogenemia Complement Factor I Deficiency
Histoplasmosis	Darling Disease Reticuloendotheliosis, X-Linked Infection By Histoplasma Capsulatum Histoplasma Infection Reticuloendothelial Cytomycosis Cytomycosis Darling Histoplasmosis African Histoplasmosis Histoplasmosis Duboisii
Hemolytic Anemia	Anemia, Hemolytic Anemia Hemolytic Anaemia Due To Other Disorders Of Glutathione Metabolism Chronic Non Spherocytic Anaemia G6pd - [Glucose-6-Phosphate Dehydrogenase Deficiency] Anaemia Anaemia Due To Glucose-6-Phosphate Dehydrogenase Deficiency Glucose-6-Phosphate Dehydrogenase Deficiency With Anaemia Glucose-6-Phosphate Dehydrogenase Deficiency Anaemia Favism Anaemia Haemolytic Anaemia Due Tog6pd Deficiency Favism Pentose Phosphate Pathway Disorder Anaemia Anaemia Due To Pentose Phosphate Pathway Defect
Louse-Borne Relapsing Fever	Relapsing Fever, Louse-Borne Relapsing Fever Due To Borrelia Recurrentis
Capillary Leak Syndrome	Systemic Capillary Leak Syndrome Clarkson Disease Capillary Leak Syndrome With Monoclonal Gammopathy Scls Periodic Systemic Capillary Leak Syndrome Capillary Hyperpermeability Syndrome Idiopathic Capillary Leak Syndrome
Exudative Glomerulonephritis
Middle Ear Cholesterol Granuloma	Cholesterin Granuloma Cholesterin Granuloma Of Middle Ear
Erythema Nodosum
Neuromyelitis Optica	Devic Disease Devic Syndrome Neuromyelitis Optica Spectrum Disorder Devic'S Disease Devic'S Syndrome Devic'S Neuromyelitis Optica Nmo Nmo Spectrum Disorder Neuromyelitis Optica Spectrum Disorders Devic Neuromyelitis Optica Optic-Spinal Ms Opticospinal Ms Nmosd Opticospinal Multiple Sclerosis Devic Ophthalmoneuromyelitis Optic Neuromyelitis Optic Neuroencephalomyelopathy Nmo - [Neuromyelitis Optica] Optic Neuritis With Demyelination
Complement Factor I Deficiency	Complement Component 3 Inactivator Deficiency C3 Inactivator Deficiency Hereditary Factor I Deficiency Disease C3 Glomerulopathy 2 CFID C3g2 Immunodeficiency With Factor I Anomaly Complete Factor I Deficiency CFI DEFICIENCY Deficiency, Complement Factor I Complement Factor I Deficiency Deficiency Of Factor 1 Hereditary Fibrinogen Deficiency Deficiency Of Fibrinogen Congenital Fibrinogenopenia
C3 Glomerulopathy	C3 Glomerulonephritis C3g Non-Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis Glomerulonephritis With Dominant C3 Ddd Ddd/Mpgnii Dense Deposit Disease Membranoproliferative Glomerulonephritis Type Ii Non-Ig-Mediated Mpgn Non-Ig-Mediated Membranoproliferative Glomerulonephritis Non-Immunoglobulin-Mediated Mpgn Membranoproliferative Glomerulonephritis, Type Ii
Hypersensitivity Reaction Type Iii Disease	Immune Complex Diseases Immune Complex Disease Type Iii Hypersensitivity Reaction Disease
Eye Disease	Eye Diseases Abnormality Of The Eye Toxoplasma Oculopathy
Lyme Disease	Lyme Borreliosis Lyme Neuroborreliosis Borreliosis Borrelia Burgdorferi Infection Neuroborreliosis Bannwarth Syndrome Bannworth'S Syndrome Neurological Lyme Disease B. Burgdorferi Infection Borreliosis, Lyme Infection By Borrelia Burgdorferi Infection Due To Borrelia Burgdorferi Sensu Lato Lym Borrelia Infections
Herpes Simplex	Herpes Simplex Infections Herpesvirus Hominis Disease Herpes Simplex Disease Herpesviral Infection Due To Herpes Simplex Infections Due To Simplex Virus Herpes Nos
Pulmonary Tuberculosis	Tuberculosis, Pulmonary PTB Tuberculosis Pulmonary
Vasculitis	Angiitis Autoimmune Vasculitis Systemic Vasculitis Vasculitis, Autoimmune
Epidermolysis Bullosa Dystrophica, Autosomal Dominant	Epidermolysis Bullosa Dystrophica, Cockayne-Touraine Type Epidermolysis Bullosa Dystrophica, Pasini Type Epidermolysis Bullosa Dystrophica, Ad Autosomal Dominant Dystrophic Epidermolysis Bullosa Generalized Dominant Dystrophic Epidermolysis Bullosa DDEB Dystrophic Epidermolysis Bullosa, Autosomal Dominant Ebdct Albopapuloid Dominant Dystrophic Epidermolysis Bullosa Ebdd Dominant Dystrophic Epidermolysis Bullosa Autosomal Dominant Dystrophic Epidermolysis Bullosa, Pasini And Cockayne-Touraine Types Ddeb, Pasini And Cockayne-Touraine Types Ddeb, Generalized Ddeb-Gen Dominant Dystrophic Epidermolysis Bullosa, Generalized Autosomal Dominant Generalized Dystrophic Epidermolysis Bullosa Generalized Ddeb Epidermolysis Bullosa Dystrophica, With Subcorneal Cleavage EBDSC Cockayne-Touraine Disease Epidermolysis Bullosa Dystrophica With Subcorneal Cleavage
Acute Diffuse Nephritis	Acute Diffuse Glomerulonephritis
Antiphospholipid Syndrome	Antiphospholipid Antibody Syndrome Hughes Syndrome Familial Antiphospholipid Syndrome Aps Lupus Anticoagulant, Familial Anti-Phospholipid Syndrome Apls Classic Apls Classic Antiphospholipid Syndrome Acromegaloid Facial Appearance Syndrome Anticardiolipin Syndrome
Hyperlipidemia, Familial Combined, 3	Familial Combined Hyperlipidemia Combined Hyperlipidemia, Familial Mixed Hyperlipidaemia FCHL3 Hyperlipidemia, Familial Combined Familial Multiple Lipoprotein-Type Hyperlipidemia Hyperbetalipoproteinemia With Prebetalipoproteinemia Type Iib Hyperlipoproteinemia Hyperlipidemia Familial Combined Hyperlipoproteinemia Type Iib Mixed Hyperlipemia Hyperlipidaemia, Group C Familial Hypercholesterolaemia With Hyperlipaemia Familial Hyperbetalipoproteinaemia And Hyperprebetalipoproteinaemia Hyperbetalipoproteinaemia With Prebetalipoproteinaemia Hypercholesterolaemia With Endogenous Hyperglyceridaemia Prebetalipoproteinemia Hyperbetalipoproteinaemia Remnant Hyperlipoproteinemia
End Stage Renal Disease	End Stage Renal Failure End-Stage Kidney Disease Kidney Failure, Chronic Chronic Kidney Disease Stage 5
Complement Component 5 Deficiency	C5 Deficiency C5D
Meningococcal Infection	Meningococcal Disease Meningococcal Infections Neisseria Meningitidis Infection Meningococcal Diseases Meningococcus Infection Due To Neisseria Meningitidis Meningococcal Disease Nos Meningococcal Infection Nos
Acute Poststreptococcal Glomerulonephritis	Post-Streptococcal Glomerulonephritis Acute Post-Streptococcal Glomerulonephritis
Purpura	Purpuric Disorder
Meningitis	Streptococcal Meningitis Acute Streptococcal Meningitis Staphylococcal Meningitis Adenoviral Meningitis Influenza Meningitis Influenzal Meningitis Meningitis Due To H. Influenzae Cryptococcal Meningitis Fungal Meningitis Due To Cryptococcus Neoformans Cryptococcosis Meningitis Cryptococcus Meningitis Cryptococcal Meningoencephalitis Meningitis Due To Cryptococcus Mumps Virus Meningitis Mumps Meningitis
Macular Degeneration, Age-Related, 1	Macular Degeneration Age-Related Macular Degeneration Macular Degeneration, Age-Related Age Related Macular Degeneration Age Related Macular Degeneration 1 ARMD1 Senile Macular Degeneration Maculopathy, Age-Related, 1 Macular Degeneration, Age-Related, Reduced Risk Of Age Related Maculopathy 1 Age Related Maculopathies Age Related Maculopathy Senile Macular Retinal Degeneration Macular Degeneration Of Retina Age-Related Maculopathy Amd Armd Age-Related Maculopathy, Susceptibility To Maculopathy Age-Related Macular Degeneration, Age-Related, 1, Susceptibility To Maculopathy, Age-Related Macular Degeneration, Age-Related, Type 1 Macular Degeneration, Age-Related, 2
Angioedema	Angioneurotic Oedema Quincke'S Edema Angioneurotic Edema Giant Urticaria
Heart Disease	Heart Failure Congenital Heart Disease Heart Diseases Congenital Heart Defects Congenital Heart Defect Heart Malformation Congenital Anomaly Of Heart Heart Defect Heart-Congenital Defect Congenital Heart Disorder Heart Defects Congenital Heart Defects, Congenital Heart Defects Heart Disease, Congenital Disease, Heart, Congenital Congestive Heart Failure
Lupus Erythematosus	Lupus Lupus Vulgaris Lupus Erythematosus, Discoid Lupus Erythematosus, Systemic Subacute Cutaneous Lupus Le - [Lupus Erythematosus]
Otitis Media	Opsoclonus-Myoclonus Syndrome OMS Otitis Media, Susceptibility To Kinsbourne Syndrome Otitis Media, Chronic/Recurrent Come/Rom Ataxo-Opso-Myoclonus Syndrome Dancing Eye Syndrome Dancing Eye-Dancing Feet Syndrome Oma Syndrome Opsoclonus Myoclonus Syndrome Opsoclonus-Myoclonus-Ataxia Syndrome Poma Syndrome Paraneoplastic Opsoclonus-Myoclonus Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Opsoclonus Myoclonus OM {Otitis Media, Susceptibility To} Infectious Otitis Media
Systemic Lupus Erythematosus	Lupus Nephritis SLE Disseminated Lupus Erythematosus Systemic Lupus Erythematosus, Susceptibility To Lupus Erythematosus, Systemic Lupus Nephritis, Susceptibility To Libman-Sacks Disease Systemic Lupus Erythematosus Susceptibility To Sle - Lupus Erythematosus, Systemic Le Syndrome Lupus Lupus Erythematosus Systemic Lupus Erythematosus, Systemic, Susceptibility To Lupus Vulgaris Lupus Erythematosus, Discoid Lupus Erythematosus Systemic Lupus Erythematosus Nos Sle - [Systemic Lupus Erythematosus]
Pyuria	Pus Cells In Urine
Degeneration Of Macula And Posterior Pole	Degeneration Of Macula And Posterior Pole Of Retina Degeneration Of Macula Or Posterior Pole Macular Degeneration Nos Degenerative Disorder Of Macula Drusen Macular Degeneration Posterior Pole Macular Degeneration Of Eye Macular Eye Degeneration Macular Degeneration Of Retina, Unspecified Pseudohole Degeneration Of Macula Of Retina
Acute Proliferative Glomerulonephritis	Acute Glomerulonephritis With Lesion Of Proliferative Glomerulonephritis Acute Post-Streptococcal Glomerulonephritis
Prostatitis
Immune-Complex Glomerulonephritis	Immune Complex Glomerulonephritis
Proliferative Glomerulonephritis
Tick-Borne Relapsing Fever	Relapsing Fever, Tick-Borne Relapsing Fever Due To Any Borrelia Species Other Than Borrelia Recurrentis African Tick-Borne Fever
Crescentic Glomerulonephritis	Idiopathic Crescentic Glomerulonephritis
Hypersensitivity Vasculitis	Cutaneous Small Vessel Vasculitis Hypersensitivity Angiitis Cutaneous Leukocytoclastic Vasculitis Leukocytoclastic Angiitis Vasculitis, Leukocytoclastic, Cutaneous Leukocytoclastic Vasculitis Cutaneous Leukocytoclastic Angiitis Cutaneous Hypersensitivity Vasculitis Vasculitis Hypersensitivity Drug Induced Cutaneous Vasculitis Allergic Vasculitis
Libman-Sacks Endocarditis	Libmann-Sachs, Endocarditis In Systemic Lupus Erythematosus
Iga Glomerulonephritis	Iga Nephropathy Glomerulonephritis, Iga Berger'S Iga Or Igg Nephropathy Focal Glomerulonephritis Primary Iga Nephropathy Segmental Glomerulonephritis Berger Disease Berger'S Disease Igan Nephritis, Iga Type Nephropathy Iga Glomerulonephritis Focal Iga Nephropathy, Susceptibility To Primary Immunoglobulin A Nephropathy
Chronic Monocytic Leukemia	Leukemia, Myeloid Leukemia, Monocytic, Chronic
Rapidly Progressive Glomerulonephritis	Glomerulonephritis Rapidly Progressive Idiopathic Crescentic Glomerulonephritis
Zebrafish Allergy	Danio Rerio Allergy
Ludwig'S Angina	Cellulitis Of Floor Of Mouth Ludwig Angina
Relapsing Fever	Febris Recurrens Novy Febris Recurrens Novy Relapsing Fever
Henoch-Schoenlein Purpura	Henoch-Schonlein Purpura Iga Vasculitis Allergic Purpura Anaphylactoid Purpura Rheumatoid Purpura Immunoglobulin A Vasculitis Vascular Purpura Purpura Rheumatica Henoch-Schönlein Purpura Autoimmune Purpura Henoch-Schnlein Purpura Henoch-Sch@Nlein Purpura Henoch-Scholein Purpura Purpura, Autoimmune Henoch Schonlein Purpura Immunoglobulin-A Vasculitis Purpura, Schonlein-Henoch Purpura, Schönlein-Henoch Hsp - Schönlein-Henoch Purpura
Malaria	Malaria, Susceptibility To Malaria, Resistance To Malaria, Cerebral Cerebral Malaria Malaria, Severe, Susceptibility To Malaria, Severe, Resistance To Malaria, Cerebral, Susceptibility To Induced Malaria Malaria, Vivax, Protection Against Malaria, Severe Malaria, Cerebral, Reduced Risk Of Malaria, Protection Against Resistance To Malaria Due To G6pd Deficiency Malaria Due To G6pd Deficiency Malarial Encephalitis CM Malaria Cerebral Susceptibility To Malaria Acute Pernicious Fever Aestivo-Autumnal Fever Aestivo Autumnal Malaria Chagres Fever Continued Malaria Fever Estivo-Autumnal Fever Estivo-Autumnal Malaria Estivo-Autumnal Malarial Fever Falciparum Fever Malignant Tertian Fever Malignant Tertian Malaria Pernicious Intermittent Fever Pernicious Malaria Quotidian Malaria Subtertian Fever Subtertian Malaria Fever Subtertian Malignant Tertian Malaria Tropical Malaria Algid Malaria Bilious Haemoglobinuric Fever Black Water Fever Blackwater Fever Malarial Blackwater Fever Severe Malarial Falciparum West African Fever Malarial Haematinuria Haemoglobinuric Fever Haemoglobinuric Malaria Severe Plasmodium Falciparum Malaria Malarial Haemoglobinuria Malarial Haematuria Falciparum Malaria [Malignant Tertian] Malaria Tropica Malarial Shock Chagres Virus Disease Malignant Malaria Mtm - [Malignant Tertian Malaria] Tm -[Malignant Tertian Malaria] Panama Fever St - [Subtertian Malaria] Malarial Quotidian Benign Tertian Malaria Tertian Ague Vivax Fever Plasmodium Vivax Malaria Nos Btm - [Benign Tertian Malaria] Bt - [Benign Tertian Malaria] Vivax Malaria Benign Tertian Vivax Malaria Tertian Malaria Quartan Malaria Quartan Ague Quartan Fever Plasmodium Malariae Malaria Nos Quartan Malarial Malaria By Plasmodium Malariae Malariae Malaria Ovale Tertian Malaria Plasmodium Ovale Fever Malaria Fever By Plasmodium Ovale Ovale Malaria Malaria By Plasmodium Ovale Malarial Ovale Marsh Fever Remittent Congestive Fever Coastal Fever Remittent Gastric Fever Miasmatic Fever Congestive Remittent Fever Intermittent Fever Jungle Fever Paludism Cameroon Fever Ague Corsican Fever Intermittent Bilious Fever Disease Due To Plasmodiidae Malarial Fever Plasmodiosis Remittent Fever Roman Fever Malaria Fever Nos Malaria Nos Paludal Fever Clinically Diagnosed Malaria Clinically Diagnosed Malaria Without Parasitological Confirmation Congestive Fever Malarial Cachexia Marsh Cachexia Paludal Cachexia Recurrent Malaria Remittent Malaria
Meningococcal Meningitis	Meningitis, Meningococcal Meningitis Meningococcal Epidemic Meningitis Meningitis Due To Neisseria Meningitidis Meningococcal Meninges Infection Meningococcal Meningeal Infection Meningococcal Cerebrospinal Inflammation Chronic Meningococcal Arachnoiditis Meningococcal Arachnoiditis Diplococcal Spinal Meningitis Diplococcal Meningitis Meningococcal Cerebrospinal Fever Meningococcal Cerebrospinal Infection Meningococcal Spinal Meningitis
Lipid Metabolism Disorder	Dyslipidemia Disorder Of Fatty Acid Metabolism Lipid Metabolism Disorders Fatty Acid Metabolism Disorder Disorder Of Lipid Metabolism Abnormality Of Lipid Metabolism Lipid Metabolism, Inborn Errors Dyslipidemias Disorders Of Lipid Metabolism Congenital Disorders Of Lipid Metabolism Inherited Disorders Of Lipid Metabolism
Anemia, Autoimmune Hemolytic	Autoimmune Hemolytic Anemia Idiopathic Autoimmune Hemolytic Anemia Immuno-Hemolytic Anemia Anemia, Hemolytic, Autoimmune Autoimmune Haemolytic Anaemia Autoimmune Hemolytic Anaemia Acquired Autoimmune Hemolytic Anemia Anemia Hemolytic Autoimmune Familial Auto-Immune Hemolytic Anemia Aha Aiha
Anti-Basement Membrane Glomerulonephritis	Anti-Gbm Glomerulonephritis
Autoimmune Disease Of Urogenital Tract
Goodpasture Syndrome	Anti-Glomerular Basement Membrane Disease Anti-Gbm Disease Pulmonary Renal Syndrome Anti-Glomerular Basement Membrane Antibody Disease Glomerulonephritis - Pulmonary Hemorrhage Rapidly Progressive Glomerulonephritis With Pulmonary Hemorrhage Anti-Gbm Syndrome Goodpasture'S Syndrome Anti-Basement Membrane Glomerulonephritis
Nephrotic Syndrome	Finnish Congenital Nephrotic Syndrome Ns - [Nephrotic Syndrome] Nephrosis Syndrome Nephrosis Nos Glomerular Lesion Nephrosis
Autoimmune Disease Of Blood
Mesangial Proliferative Glomerulonephritis	Glomerulonephritis - Mesangial Proliferative Mesangial Proliferative Gn Mesangioproliferative Glomerulonephritis Glomerulonephritis Mesangial Proliferative
Cataract 23, Multiple Types	Cataract 23 CTRCT23 Lamellar Cataract 23 Cataract 23, Multiple Types, With Or Without Microcornea Isolated Microphthalmia With Cataract 4 Mcopct4 Cataract, Type 23 Microphthalmia, Isolated, With Cataract 4
Hereditary Angioedema	Hereditary Angioneurotic Edema Hereditary Angioedema Type 1 Hane Angioedema, Hereditary Hae Angioedemas, Hereditary Deficiency Of C1 Esterase Inhibitor C1 Esterase Inhibitor Deficiency C1 Inhibitor Deficiency Familial Angioneurotic Edema Hereditary Bradykinine-Induced Angioedema Hereditary Non Histamine-Induced Angioedema Hae 1 Hae-I Hereditary Angioneurotic Edema Type 1 Hereditary C1 Esterase Inhibitor Deficiency - Deficient Factor Hereditary Angioedema Types I And Ii Hereditary Angioneurotic Oedema Familial Angioedema Hae - [Hereditary Angioneurotic Oedema] Bannister Disease, Hereditary Quincke Disease Or Oedema Hereditary Quincke Oedema
Thrombocytopenia	Low Platelet Count Low Platelets Decreased Platelets Platelet Dysfunction Nos
Body Mass Index Quantitative Trait Locus 11	OBESITY Obesity, Susceptibility To Leanness, Inherited Obesity, Susceptibility To, Bmiq11 Obesity, Mild, Early-Onset Obesity, Association With Obesity, Early-Onset, Susceptibility To Obesity, Severe Obesity, Severe, And Type Ii Diabetes Obesity, Late-Onset Obesity , Susceptibility To BMIQ11 Obesity Bmiq11 Obesity, Early-Onset Simple Obesity Nos Excess Fat Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified Adiposis
Retinitis Pigmentosa 46	RP46 Retinitis Pigmentosa, Autosomal Recessive, Idh3b-Related Retinitis Pigmentosa Autosomal Recessive Idh3b-Related Retinitis Pigmentosa, Type 46
3mc Syndrome	Craniofacial-Ulnar-Renal Syndrome Malpuech Facial Clefting Syndrome Oculopalatoskeletal Syndrome Carnevale Syndrome Michels Syndrome Malpuech-Michels-Mingarelli-Carnevale Syndrome Carnevale-Krajewska-Fischetto Syndrome Craniosynostosis With Lid Anomalies Malpuech Syndrome Mingarelli Syndrome Oculo-Skeletal-Abdominal Syndrome Osa Syndrome Ptosis Of Eyelids With Diastasis Recti And Hip Dysplasia Ptosis-Strabismus-Rectus Abdominis Diastasis
Diabetes Mellitus	Diabetes
Eye Degenerative Disease
Autoimmune Disease Of Musculoskeletal System
Type 2 Diabetes Mellitus	Insulin Resistance NIDDM Type 2 Diabetes Diabetes Mellitus, Non-Insulin-Dependent T2D Noninsulin-Dependent Diabetes Mellitus Diabetes Mellitus, Type Ii Maturity-Onset Diabetes Insulin Resistance, Severe, Digenic Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Noninsulin-Dependent, Association With Diabetes Mellitus, Noninsulin-Dependent, Late Onset Hypertension, Insulin Resistance-Related, Susceptibility To Insulin Resistance, Susceptibility To Non-Insulin-Dependent Diabetes Mellitus Type Ii Diabetes Mellitus Adult-Onset Diabetes Mellitus Maturity-Onset Diabetes Mellitus Diabetes Mellitus Type 2 Type Ii Diabetes Type 2 Diabetes Mellitus, Susceptibility To Diabetes, Type 2 Diabetes Mellitus, Noninsulin-Dependent, Susceptibility To Diabetes Mellitus, Non-Insulin-Dependent, Susceptibility To Diabetes Mellitus, Type 2, Susceptibility To Diabetes Mellitus, Noninsulin-Dependent, 2 Diabetes Mellitus, Type Ii, Susceptibility To Hypertension, Insulin Resistance-Related Adult-Onset Diabetes Aodm Diabetes Mellitus, Adult-Onset Diabetes Mellitus Type Ii Diabetes Mellitus Type 2, Susceptibility To Diabetes, Type Ii, Susceptibility To Diabetes Type 2 Diabetes Mellitus Adult Onset Diabetes Maturity Onset Diabetes Nonketotic Diabetes Non-Insulin Dependent Diabetes Mellitus T2dm - [Type 2 Diabetes Mellitus] Niddm - [Non Insulin Dependent Diabetes Mellitus] Dm2 Dm Type Ii Diabetic Type 2 Insulin Requiring Type 2 Diabetes Noninsulin Dependent Diabetes Non-Insulin-Dependent Diabetes Mellitus Without Complications Diabetes Due To Insulin Secretory Defect Diabetes Mellitus Due To Insulin Secretory Defect Non-Insulin-Dependent Diabetes Of The Young Senile Diabetes Nonketotic Hyperglycaemia Stable Diabetes
Blood Platelet Disease	Platelet Disorder Blood Platelet Disorders Thrombocytopathy Platelet Dysfunction Platelet Disorders Qualitative Platelet Deficiency
Cystic Fibrosis	Mucoviscidosis CF Pseudomonas Aeruginosa, Susceptibility To Chronic Infection By, In Cystic Fibrosis Pseudomonas Aeruginosa Chronic Infection By, In Cystic Fibrosis Cystic Fibrosis Lung Disease, Modifier Of Cystic Fibrosis Of Pancreas Fibrocystic Disease Of Pancreas Cf - [Cystic Fibrosis] Cystic Fibrosis Nos Fibrocystic Disease Fibrocystic Disease Of The Pancreas Mucoviscidosis Of Pancreas Nonproliferative Fibrocystic Disease Pancreatic Cystic Fibrosis
Prader-Willi Syndrome	Prader-Labhart-Willi Syndrome PWS Willi-Prader Syndrome Prader-Willi Syndrome Due To Translocation Prader-Willi Syndrome Due To Imprinting Mutation Prader-Willi Syndrome Due To Maternal Uniparental Disomy Of Chromosome 15 Prader Willi Syndrome Upd(15)Mat
Hypertension, Essential	Essential Hypertension Hypertension High Blood Pressure Hypertension, Essential, Susceptibility To Hypertensive Disease Primary Hypertension EHT Hypertension, Salt-Sensitive Essential, Susceptibility To Hyperpiesia Idiopathic Hypertension Hypertensive Disorder Hypertension, Essential, Susceptibility To, 3 Hypertension, Essential 3 Hypertension, Essential, Salt-Sensitive Hypertension, Essential, Susceptibility To, 6 Hypertension, Essential 6 Hypertension, Salt-Sensitive Essential Hypertension, Susceptibility To Hypertension, Essential, Susceptibility To, 4 Hypertension, Essential 4 Hypertension, Essential, Susceptibility To, 2 Hypertension, Essential 2 Hypertension, Essential, Susceptibility To, 1 Hypertension, Essential 1 Hypertension, Essential, Susceptibility To, 5 Hypertension, Essential 5 Htn Vascular Hypertensive Disorder Systemic Primary Arterial Hypertension Hbp - [High Blood Pressure] Systemic Arterial Hypertensive Disorder Elevated Blood Pressure Arterial Hypertension Nos Hypertension Nos Benign Hypertension Systemic Arterial Hypertension Systemic Hypertension Artery Htn Benign Htn Vascular Htn Vascular Hypertension Cholesterol Hypertension Cholesterol Htn Idiopathic Htn Malignant Hypertension Malignant Htn Raised Blood Pressure Cardiovascular Hypertension Primary Htn - [Hypertension] High Arterial Tension High Blood Pressure Disorder Ht - [Hypertension] Htn - [Hypertension] Hypertensive Vascular Disease Hypertensive Vascular Degeneration
Skin Disease	Skin Diseases Genodermatosis Abnormality Of The Skin Skin Diseases, Genetic Skin And Subcutaneous Tissue Disease Dermatologic Disorders
Nervous System Disease	Abnormality Of The Nervous System Nervous System Diseases Nervous System Disorder

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (3)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-127105	Iptacopan	Inhibitor	99.95%	Yes
HY-127105A	Iptacopan hydrochloride	Inhibitor	99.88%	Yes
HY-200854	Iptacopan hydrochloride hydrate	Inhibitor	/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P99050	Sutimlimab	Inhibitor	98.81%	Unkown

Clinical Phase

Bioactive Molecules (19)

Cat. No.	Product Name	Effect	Purity	Phase
HY-14605BS	Rasagiline-13C3 mesylate racemic	Inhibitor	/	Phase 4
HY-P3252A	Pegcetacoplan acetate	Inhibitor	99.92%	Phase 3
HY-132295	Azenosertib	Inhibitor	99.96%	Phase 3
HY-P2141	TRV-120027	Agonist	98.21%	Phase 3
HY-106178	PMX-53	Antagonist	99.95%	Phase 2
HY-P1717A	AMY-101 TFA	Inhibitor	99.92%	Phase 2
HY-N9481	Lipoteichoic acid		/	Phase 2
HY-19903	ASP-9521		98.0%	Phase 2
HY-124573	(R)-Odafosfamide		98.52%	Phase 2
HY-P3204	POT-4	Inhibitor	98.88%	Phase 2
HY-171544	AGS-16C3F		99.81%	Phase 2
HY-149040	Odafosfamide		99.06%	Phase 2
HY-156701	BAY-1128688		/	Phase 2
HY-181146	MK-7762	Inhibitor	/	Phase 2
HY-P1717	AMY-101	Inhibitor	99.86%	Phase 1
HY-10819	AG2034		/	Phase 1
HY-143439	LX-039	Antagonist	/	Phase 1
HY-114913	Fenarimol	Inhibitor	99.78%	Phase 1
HY-119051	BR111		/	Phase 1

Inhibitory Antibodies (4)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P990091	Riliprubart	Inhibitor	99.90%	Phase 3
HY-P990025	Empasiprubart		≥99.0%	Phase 3
HY-P99905	Efdamrofusp alfa		99.89%	Phase 3
HY-P991022	Ruxoprubart	Inhibitor	95.541%	Phase 2

Pre-clinical Phase

Bioactive Molecules (748)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-101502A	SB290157 trifluoroacetate	Antagonist	99.87%	Unkown
HY-12481	SAR405	Inhibitor	99.74%	Unkown
HY-N0376	Liquiritin		99.99%	Unkown
HY-Y0479S	L-Lactic acid-13C3		99.9%	Unkown
HY-138161	JR14a	Antagonist	99.77%	Unkown
HY-P1036	Compstatin	Inhibitor	99.83%	Unkown
HY-15978	P7C3-A20		99.32%	Unkown
HY-W021005	Silver bis(trifluoromethanesulfonyl)imide		99.90%	Unkown
HY-P2848	Cholesterol oxidase, Microorganism		≥90.0%	Unkown
HY-N0650S	L-Serine-13C3		99.95%	Unkown
HY-W015913S	Pyruvic acid-13C3 sodium	Inhibitor	99.7%	Unkown
HY-NP004	Cobra Venom Factor	Activator	99.07%	Unkown
HY-Y0479AS	L-Lactic acid-13C3 sodium (20% w/w in water)		99.91%	Unkown
HY-P1717B	AMY-101 acetate	Inhibitor	99.93%	Unkown
HY-103007	TC-G-1008	Agonist	99.36%	Unkown
HY-150644	S07-2010		98.35%	Unkown
HY-Y0337S	L-Cysteine-13C3,15N		99.9%	Unkown
HY-108568	15-Deoxy-Δ-12,14-prostaglandin J2	Agonist	≥99.0%	Unkown
HY-B1659S5	Glycerol-13C3		99.69%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-128358	MR-L2	Activator	98.63%	Unkown
HY-107379	AKR1C3-IN-1		98.21%	Unkown
HY-134222A	N-Acetylserine	Inhibitor	98.0%	Unkown
HY-15976	P7C3		99.66%	Unkown
HY-128132	C3a receptor agonist 1	Agonist	98.16%	Unkown
HY-112633	SMN-C3	Modulator	99.48%	Unkown
HY-133618	Pomalidomide-C3-adavosertib		99.84%	Unkown
HY-W004701	Br-C3-methyl ester		99.12%	Unkown
HY-161022A	FL118-C3-O-C-amide-C-NH2 formate		96.49%	Unkown
HY-125877	PROTAC Mcl1 degrader-1	Inhibitor	98.13%	Unkown
HY-126521	N3-C3-NHS ester		99.85%	Unkown
HY-Y0337S4	L-Cysteine-13C3		99.9%	Unkown
HY-113128S	sn-Glycerol 3-phosphate-13C3 disodium		99.9%	Unkown
HY-N0650S5	L-Serine-13C3,15N		99.9%	Unkown
HY-162266	C3TD879		98.61%	Unkown
HY-40145	1-Boc-3-iodoazetidine		99.79%	Unkown
HY-E70528	HRV-3C protease fuses with GST		/	Unkown
HY-138557	AKR1C3-IN-4		99.77%	Unkown
HY-P1505A	C3a (70-77) TFA		99.79%	Unkown
HY-152189	S19-1035		99.93%	Unkown
HY-B1337S4	Choline Chloride-13C3		99.69%	Unkown
HY-140928	Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne		95.0%	Unkown
HY-N6978	Ascr#5		98.0%	Unkown
HY-107551	Hh Pathway-IN-1		99.06%	Unkown
HY-117992	BR103		99.66%	Unkown
HY-N4134	Ciwujianoside C3	Inhibitor	99.73%	Unkown
HY-145225	DLin-K-C3-DMA	Chemical	98.59%	Unkown
HY-B0430S	Pantothenic acid-13C3,15N hemicalcium		99.3%	Unkown
HY-D1581	BODIPY 505/515-8-C3-COOH		99.92%	Unkown
HY-W008567	N-Deschlorobenzoyl indomethacin		95.0%	Unkown
HY-147090	Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH	Degrader	99.06%	Unkown
HY-163962	L18I		99.89%	Unkown
HY-N0229S8	L-Alanine-13C3		99.90%	Unkown
HY-N10361	Drupanin		99.35%	Unkown
HY-RI00407	hsa-miR-200c-3p inhibitor		96.28%	Unkown
HY-144432S	D-Pantothenic acid-13C3,15N hemicalcium hemihydrate		99.7%	Unkown
HY-163032	FABP4-IN-3	Inhibitor	99.64%	Unkown
HY-I0400S3	N-Acetylneuraminic acid-13C-3		99.0%	Unkown
HY-100683	A12B4C3	Inhibitor	98.06%	Unkown
HY-148142	Pomalidomide-C3-NHS ester		98.70%	Unkown
HY-W683760	N-Nitrosonornicotine		99.97%	Unkown
HY-B1773AS3	Sodium propionate-13C3		99.45%	Unkown
HY-P2141A	TRV-120027 TFA	Agonist	99.62%	Unkown
HY-109154	Obafistat	Inhibitor	99.92%	Unkown
HY-145127	ETZ		99.84%	Unkown
HY-155035	S07-1066		99.48%	Unkown
HY-N0229S10	L-Alanine-13C3,15N		98.0%	Unkown
HY-N0680S3	Thiamine-13C3 hydrochloride		99.9%	Unkown
HY-N1981S	Triolein-13C3	Inhibitor	98.00%	Unkown
HY-W004617	2,4,6-Tris(4-carboxyphenyl)-1,3,5-triazine		99.01%	Unkown
HY-W004640	N-Boc-C1-PEG3-C3-NH2		98.0%	Unkown
HY-W007376S	Indole-3-carboxaldehyde-13C		97.39%	Unkown
HY-40354S	Tofacitinib-13C3		99.77%	Unkown
HY-P1036A	Compstatin TFA	Inhibitor	99.11%	Unkown
HY-D1342	Coumberol		99.99%	Unkown
HY-R00407	hsa-miR-200c-3p mimic		95.41%	Unkown
HY-B0710S	Betaine-13C3		99.86%	Unkown
HY-131185	Pomalidomide-amido-C3-COOH		99.69%	Unkown
HY-130711B	(S,R,S)-AHPC-C3-NH2 hydrochloride		96.68%	Unkown
HY-140902A	Biotin-PEG3-C3-NH2		97.0%	Unkown
HY-N0322S4	Cholesterol-13C3	Agonist	98.80%	Unkown
HY-B0356AS1	Ciprofloxacin-13C3,15N monohydrochloride		99.9%	Unkown
HY-W077634	3-Amino-5-hydroxybenzoic acid		99.83%	Unkown
HY-12481A	SAR405 R enantiomer	Control	99.94%	Unkown
HY-130142A	Biotinyl-NH-PEG3-C3-amido-C3-COOH		99.25%	Unkown
HY-131888	Pomalidomide-C3-NH2 hydrochloride		99.72%	Unkown
HY-133479	Tetrazine-Ph-NHCO-C3-NHS ester		98.40%	Unkown
HY-152188	AKR1C3-IN-9		99.77%	Unkown
HY-157510	Thalidomide-O-C3-azide		98.41%	Unkown
HY-159604	METTL3-IN-9	Inhibitor	95.30%	Unkown
HY-172314	ACHM-025		98.06%	Unkown
HY-N0351S	p-Coumaric acid-13C3		99.12%	Unkown
HY-N3205	Neochamaejasmin B		98.53%	Unkown
HY-W010407S	Cyanuric acid-13C3		98.0%	Unkown
HY-W013061S1	Propane-1,2,3-triyl tripalmitate-13C3		98.0%	Unkown
HY-113008AS	cis-Urocanic acid-13C3	Agonist	99.46%	Unkown
HY-R04629	hsa-miR-29c-3p mimic		98.48%	Unkown
HY-W414731	N-(3-Methylphenyl)anthranilic acid		99.82%	Unkown
HY-N0650S3	L-Serine-13C3,15N,d3		≥99.90%	Unkown
HY-100196S1	Pyrroloquinoline quinone-13C3 sodium		99.29%	Unkown
HY-103608	(S,R,S)-AHPC-(C3-PEG)2-C6-Cl		98.85%	Unkown
HY-108568S	15-Deoxy-Δ-12,14-prostaglandin J2-d4	Agonist	98.10%	Unkown
HY-128856	P7C3-OMe		98.26%	Unkown
HY-133584	Bis-SS-C3-NHS ester		98.0%	Unkown
HY-15129S	O-Phospho-L-serine-13C3,15N	Modulator	99.19%	Unkown
HY-158118	Lys(CO-C3-p-I-Ph)-OMe		97.19%	Unkown
HY-160897	Methoxy-PEG2000-C3-amide-C2-Mal		99.69%	Unkown
HY-161022S1	FL118-C3-O-C-amide-C-NH2-d5 formate		/	Unkown
HY-162816	PROTAC HPK1 Degrader-3		/	Unkown
HY-163940	LX1		99.13%	Unkown
HY-N0136S1	(±)-Taxifolin-13C3	Inhibitor	99.63%	Unkown
HY-N0230S	β-Alanine-13C3,15N		99.99%	Unkown
HY-N0898S	Catechin-13C3		98.06%	Unkown
HY-N7404S1	Nε,Nε,Nε-Trimethyllysine-13C3 chloride		98.0%	Unkown
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	99.23%	Unkown
HY-R00006	hsa-let-7c-3p mimic		93.63%	Unkown
HY-R00717	hsa-miR-34c-3p mimic		94.18%	Unkown
HY-R01568	hsa-miR-518c-3p mimic		92.33%	Unkown
HY-R01678	hsa-miR-548c-3p mimic		92.16%	Unkown
HY-W442078	Iodine-C3-O-C3-PEG-Boc		≥98.0%	Unkown
HY-113294S	3-Hydroxykynurenine-13C3,15N	Inducer	99.0%	Unkown
HY-171115	Pyrone-211		99.32%	Unkown
HY-403561	2-MSP-C3-NHS ester		/	Unkown
HY-W1120221	Lenalidomide-C3-NH2		/	Unkown
HY-W336094	1,3-Glyceryl dilinoleate		/	Unkown
HY-115560A	Thalidomide-O-amido-C3-NH2 TFA	Inducer	99.58%	Unkown
HY-131646	Thalidomide-O-amido-C3-PEG3-C1-NH2	Inducer	99.08%	Unkown
HY-N1428S3	Citric acid-13C3	Inhibitor	98%	Unkown
HY-103612	Thalidomide-O-amido-C3-COOH	Inducer	98.88%	Unkown
HY-111297	BMVC4		/	Unkown
HY-116170	SN34037	Inhibitor	99.02%	Unkown
HY-120903	DBCO-C3-Acid		99.68%	Unkown
HY-131455A	Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA		98.0%	Unkown
HY-135306	Cl-C6-PEG4-C3-COOH		99.65%	Unkown
HY-138847A	Thalidomide-4-O-C3-NH2 hydrochloride	Inducer	/	Unkown
HY-140808	Azido-PEG3-C3-OH		98.0%	Unkown
HY-140841	APN-C3-PEG4-azide		97.97%	Unkown
HY-148608	LysoPalloT-NH-amide-C3-ph-m-O-C11	Agonist	/	Unkown
HY-158122	Lys(CO-C3-p-I-Ph)-O-tBu		98.14%	Unkown
HY-161022	FL118-C3-O-C-amide-C-NH2		/	Unkown
HY-161022S	FL118-C3-O-C-amide-C-NH2-d5		/	Unkown
HY-161708	PROTAC FLT3/CDKs degrader-1	Degrader	/	Unkown
HY-163678	Pomalidomide-CO-C7-NH-CO-C3-COOH		98.55%	Unkown
HY-176084	RJG-2051		99.42%	Unkown
HY-B0150S1	Nicotinamide-15N,13C3	Inhibitor	98.88%	Unkown
HY-B0234S	Estrone-13C3	Agonist	98.0%	Unkown
HY-B0389S9	D-Glucose-13C3-2		98%	Unkown
HY-B0495S	Lamotrigine-13C3,d3		97.46%	Unkown
HY-B0891S1	17α-Hydroxyprogesterone-13C3	Agonist	98.9%	Unkown
HY-B1804S	Tricaprilin-13C3		98.0%	Unkown
HY-D1056A5	Lipopolysaccharides, from E. coli K-235	Activator	/	Unkown
HY-N0172S	Caffeic acid-13C3	Inhibitor	/	Unkown
HY-N0437S2	Progesterone-13C3	Agonist	99.60%	Unkown
HY-N0464S	Quinic acid-13C3	Inhibitor	99.5%	Unkown
HY-N0610AS2	Cinnamic acid-13C3		99.91%	Unkown
HY-N0771S6	L-Cysteine-13C3,15N,d3		99.6%	Unkown
HY-N2041S4	Myristic acid-13C3		99.9%	Unkown
HY-N2362S1	DL-Alanine-13C-3		98.0%	Unkown
HY-P1398	Compstatin control peptide	Control	99.95%	Unkown
HY-P1505	C3a (70-77)		/	Unkown
HY-P2325	Exoenzyme C3, clostridium botulinum	Inhibitor	/	Unkown
HY-R00333	hsa-miR-181c-3p mimic		94.69%	Unkown
HY-R00407A	hsa-miR-200c-3p agomir		/	Unkown
HY-R00840	hsa-miR-376c-3p mimic		93.13%	Unkown
HY-R01112	hsa-miR-449c-3p mimic		99.11%	Unkown
HY-R02698	mmu-miR-181c-3p mimic		99.43%	Unkown
HY-R02897	mmu-miR-302c-3p mimic		98.79%	Unkown
HY-RI00333	hsa-miR-181c-3p inhibitor		99.68%	Unkown
HY-RI00840	hsa-miR-376c-3p inhibitor		99.33%	Unkown
HY-RS01743	C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10521	Pik3c3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W010421S	Ammelide-13C3		99.85%	Unkown
HY-W024692	Indomethacin methylester		99.92%	Unkown
HY-W099927	[C3MPr]NTf2		97.0%	Unkown
HY-W654331	Quinolinic acid-13C3, 15N		99.76%	Unkown
HY-Y1117S2	Melamine-15N3,13C3		96.08%	Unkown
HY-Y1662	D-Aminoacylase		/	Unkown
HY-131800A	3'-NH2-ATP tetrasodium, 100 mM Solution		98.70%	Unkown
HY-158861	C3-K2-E14		98.5%	Unkown
HY-160773A	DBCO-C3-amide-PEG6-NHS ester		95.20%	Unkown
HY-19903R	ASP-9521 (Standard)		94.47%	Unkown
HY-43193	Cl-C6-PEG3-C3-acid		≥97.0%	Unkown
HY-RI04616	hsa-miR-29c-3p inhibitor		97.78%	Unkown
HY-RS21501	C3ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W046063	O-Phthalimide-C3-acid		/	Unkown
HY-W069545	(S)-1-Tetralol		99.75%	Unkown
HY-W112031	OH-PEG2-C3-NH2		≥95.0%	Unkown
HY-W392808	Spacer phosphoramidite C3		98.0%	Unkown
HY-W422359A	2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride		95.27%	Unkown
HY-W590573	C3 Ceramide		98.49%	Unkown
HY-W686763	Triacetylphloroglucinol		99.95%	Unkown
HY-W747332	Pyruvic aldehyde-13C3 (20% in water)		95.0%	Unkown
HY-W769017	Thiothiamine-13C3		/	Unkown
HY-W018171S2	3,5,6-Trichloro-2-pyridinol-13C3		/	Unkown
HY-18085S2	Quercetin-13C3		/	Unkown
HY-115560	Thalidomide-O-amido-C3-NH2	Inducer	/	Unkown
HY-116084S1	Trimethylamine-N-oxide-13C3	Activator	/	Unkown
HY-130711A	(S,R,S)-AHPC-C3-NH2 TFA		/	Unkown
HY-131876	Thalidomide-O-C3-acid	Inducer	/	Unkown
HY-135900	Aniline-MPB-amino-C3-PBD	Inhibitor	/	Unkown
HY-15097S	Myricetin-13C3	Inducer	/	Unkown
HY-B0412S3	Estriol-13C3	Antagonist	/	Unkown
HY-130711	(S,R,S)-AHPC-C3-NH2		/	Unkown
HY-131186	Pomalidomide-amido-C3-piperazine-N-Boc		/	Unkown
HY-105414	Esterbut-3		/	Unkown
HY-105969	Dichloromethotrexate		/	Unkown
HY-111843	Ch55-O-C3-NH2		/	Unkown
HY-113008S1	Urocanic acid-13C3		/	Unkown
HY-113357S	m-Coumaric acid-13C3		/	Unkown
HY-114773	N-Undecanoyl-L-homoserine lactone		/	Unkown
HY-115902	FGFR4-IN-7		/	Unkown
HY-116021S	Buquinolate-13C3	Inhibitor	/	Unkown
HY-116025	APN-C3-PEG4-alkyne		/	Unkown
HY-116295	MRS2690		/	Unkown
HY-116295A	MRS2690 disodium		/	Unkown
HY-121656	AKR1C2/3-IN-2	Inhibitor	/	Unkown
HY-12210	(S)-BI-1001	Inhibitor	/	Unkown
HY-12216S	Resmetirom-13C3,15N	Agonist	/	Unkown
HY-122888	MPT0L145		/	Unkown
HY-123732	CRT0083914		/	Unkown
HY-124456	Unguinol	Inhibitor	/	Unkown
HY-12542S	Dantrolene-13C3	Inhibitor	99.0%	Unkown
HY-126287	JND4135		/	Unkown
HY-127105B	Iptacopan TFA	Inhibitor	/	Unkown
HY-128748S4	DL-Glyceraldehyde-13C3		/	Unkown
HY-128753S4	D-Lyxose-13C-3		/	Unkown
HY-130142	Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA)		/	Unkown
HY-130585S	Estradiol undecylate-13C3		/	Unkown
HY-130711C	(S,R,S)-AHPC-C3-NH2 dihydrochloride		/	Unkown
HY-131184	N-Boc-piperazine-C3-COOH		/	Unkown
HY-131190	N-Boc-SBP-0636457-O-C3-COOH		/	Unkown
HY-131606S	Cidofovir diphosphate-13C3	Inhibitor	/	Unkown
HY-131801A	3'-NH2-GTP tetrasodium		/	Unkown
HY-131888A	Pomalidomide-C3-NH2		/	Unkown
HY-133403A	Biotin-C1-PEG3-C3-amine TFA		/	Unkown
HY-133585	Bis-SS-C3-sulfo-NHS ester		/	Unkown
HY-133702	Aniline-piperazine-C3-NH-Boc		/	Unkown
HY-134679	N-Boc-C1-PEG5-C3-NH2		/	Unkown
HY-134692	Azido-C1-PEG3-C3-NH2		/	Unkown
HY-134693	Azido-C1-PEG4-C3-NH2		/	Unkown
HY-134749	Propargyl-PEG2-urea-C3-triethoxysilane		/	Unkown
HY-135901	Py-MPB-amino-C3-PBD	Inhibitor	/	Unkown
HY-13599S3	Cladribine-13C3,15N3		/	Unkown
HY-13632S1	Exemestane-13C3	Inhibitor	/	Unkown
HY-136457S	2-NP-AHD-13C3		/	Unkown
HY-137842	L-Alanine-2-naphthylamide	Substrate	/	Unkown
HY-138847	Thalidomide-O-C3-NH2	Inducer	/	Unkown
HY-138850	Thalidomide-NH-amido-C3-NH2	Inducer	/	Unkown
HY-138850A	Thalidomide-NH-amido-C3-NH2 hydrochloride	Inducer	/	Unkown
HY-139145S	Etbicyphat-13C3		/	Unkown
HY-139427S	3-Methylglutaconic acid-13C3		/	Unkown
HY-139545	Thalidomide-4-C3-NH2 hydrochloride	Inducer	/	Unkown
HY-139721	Tenofovir-C3-O-C15-CF3 ammonium	Inhibitor	/	Unkown
HY-139722	Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium	Inhibitor	/	Unkown
HY-140019	Azido-PEG3-amide-C3-triethoxysilane		/	Unkown
HY-140237	Boc-Gly-amido-C-PEG3-C3-amine		/	Unkown
HY-140288	DBCO-C3-PEG4-amine		/	Unkown
HY-140295	DBCO-C3-PEG4-NH-Boc		/	Unkown
HY-140347	APN-C3-NH-Boc		/	Unkown
HY-140478	Boc-NH-PEG4-C3-acid		/	Unkown
HY-140902	rel-Biotin-PEG3-C3-NH2		/	Unkown
HY-140927	Azido-C3-UV-biotin		/	Unkown
HY-141065	N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5		/	Unkown
HY-141182	TCO-C3-PEG3-C3-amine		/	Unkown
HY-141185	TCO-PEG3-amide-C3-triethoxysilane		/	Unkown
HY-141407	m-PEG3-amido-C3-triethoxysilane		/	Unkown
HY-141597	Acid-C3-SSPy		/	Unkown
HY-141651	(S,R,S)-AHPC-C3-COOH		/	Unkown
HY-141857S	5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3		/	Unkown
HY-141893	3-Cyanovinylcarbazole phosphoramidite	Inhibitor	/	Unkown
HY-141901S2	Dehydroepiandrosterone-13C3		/	Unkown
HY-141907S	17β-Estradiol-13C3		98.1%	Unkown
HY-142140S	3-epi-25-Hydroxy Vitamin D3-d6		/	Unkown
HY-143342	LEB-03-144		/	Unkown
HY-143400	HSP70-IN-3	Inhibitor	/	Unkown
HY-143687S	3-Cyano Gimeracil methyl ether-13C3		/	Unkown
HY-144749	AKR1C3-IN-5		/	Unkown
HY-145253	Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	Unkown
HY-145254	Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	Unkown
HY-145255	Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH	Inhibitor	/	Unkown
HY-14605S	Rasagiline-13C3 mesylate		/	Unkown
HY-146573	AKR1C3-IN-6		/	Unkown
HY-146574	AKR1C3-IN-7		/	Unkown
HY-146575	AKR1C3-IN-8		/	Unkown
HY-148471A	C3-Amide-C4-NH2		/	Unkown
HY-148515	(S,R)-AHPC-O-C3-O-COOH		/	Unkown
HY-149560	Thalidomide-5-O-C3-NH2 hydrochloride	Inducer	99.08%	Unkown
HY-150624	SARS-CoV-2 nsp13-IN-3	Inhibitor	/	Unkown
HY-150646	S07-2009		/	Unkown
HY-150648	S07-2008		/	Unkown
HY-150649	S07-2005 (racemic)		/	Unkown
HY-150650	S07-2001		/	Unkown
HY-150658S2	DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C3		/	Unkown
HY-151997S	1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3		/	Unkown
HY-153456	Hedgehog IN-2	Inhibitor	/	Unkown
HY-153539	AP-C3	Inhibitor	/	Unkown
HY-153540	AP-C4	Inhibitor	/	Unkown
HY-15398S1	Vitamin D3-13C3	Activator	/	Unkown
HY-155259	Pomalidomide-5-C3-NH2 hydrochloride		96.02%	Unkown
HY-155502	AKR1C3-IN-10		/	Unkown
HY-155716	G43-C3-TEG	Inhibitor	/	Unkown
HY-157541S	2-Chloro-1,3-propanediol-13C3		/	Unkown
HY-157810	AKR1C3-IN-11		/	Unkown
HY-158383	Pomalidomide-CO-C3-PEG4-C6-NH2		/	Unkown
HY-158732	MAO-B-IN-33	Inhibitor	/	Unkown
HY-158994S	MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA		/	Unkown
HY-15977	(S)-P7C3-OMe		/	Unkown
HY-161131	Lenalidomide 4'-alkyl-C3-azide		/	Unkown
HY-161468	Thalidomide-N-C3-O-C4-O-C3-OH	Inducer	/	Unkown
HY-161653	Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	Unkown
HY-161832	(S,R,S)-Me-AHPC-amide-C3-alkyne		/	Unkown
HY-161839	AKR1C2/3-IN-1		/	Unkown
HY-162714	C3N-Dbn-Trp2	Inhibitor	/	Unkown
HY-163223	(S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc		/	Unkown
HY-163323	AKR1C3-IN-12		/	Unkown
HY-163609	PROTAC AKR1C3 degrader-1		/	Unkown
HY-163610	AKR1C3-IN-13		/	Unkown
HY-163758	COOH-C3-CONH-C7-COOH		/	Unkown
HY-163784	AKR1C3-IN-14		/	Unkown
HY-163821	HO-CONH-C3-PEG3-NH2		/	Unkown
HY-163903	OH-C2-PEG3-NHCO-C3-COOH		/	Unkown
HY-163904	(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH		/	Unkown
HY-163964	Lenalidomide-C3-PEG3-N3		/	Unkown
HY-164085	Azide-C3-NHCO-C3-NHS ester		/	Unkown
HY-164909	PZ-3022		/	Unkown
HY-168239	Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph		/	Unkown
HY-169401	L321-NH-C3-PEG3-C1-NH2		/	Unkown
HY-170531	SR 142948-C3-NHMe		/	Unkown
HY-170808	PROTAC BRD4 Degrader-28	Degrader	/	Unkown
HY-170867	Nrf2/HO-1 activator 3		/	Unkown
HY-170978	PROTAC CDK9 degrader-11	Degrader	/	Unkown
HY-172804	SDH-IN-26		/	Unkown
HY-173132	AKR1Cs-IN-1		/	Unkown
HY-173453	AKR1C3-IN-15		/	Unkown
HY-173500	MG-3C		/	Unkown
HY-174384	MET Transcription-IN-1		/	Unkown
HY-17461S	Cortisone-13C3	Agonist	/	Unkown
HY-175074	C3 BODIPY Ganglioside GM1 (d18:1/3:0) ammonium		/	Unkown
HY-175193	N-Deshydroxyethyl Dasatinib-C3-NH2	Inhibitor	/	Unkown
HY-175754	C3TD078	Inhibitor	/	Unkown
HY-175936	NH2-C3-piperazin-Pip-Boc		/	Unkown
HY-176037	Boc-C3-amide-C10-amine		/	Unkown
HY-176243	15-Deoxy-Δ12,14-Prostaglandin J2-2-glyceryl ester	Agonist	/	Unkown
HY-176335	TBK1 ligand 2-C-O-C4-O-C3-O-C-amide	Inhibitor	/	Unkown
HY-176363	Adavosertib-C3-NH-Boc	Inhibitor	/	Unkown
HY-176364	AZD9496-O-C3-O-C3-O-C-acid	Inhibitor	/	Unkown
HY-176385	3-Fluoro-desmethyl-cabozantinib-C3-O-C3-PEG-acid	Ligand	/	Unkown
HY-176978	(S,S,S)-Me-AHPC-amide-C3-alkyne		/	Unkown
HY-177148	G256	Substrate	/	Unkown
HY-177148A	G256 dihydrochloride	Substrate	/	Unkown
HY-177621	Cevolisiran	Inhibitor	/	Unkown
HY-177621A	Cevolisiran sodium	Inhibitor	/	Unkown
HY-177802	C3 sodium	Inhibitor	/	Unkown
HY-178284	Factor B-IN-7	Inhibitor	/	Unkown
HY-178299S	3-Amino-5-hydroxybenzoic acid-13C		/	Unkown
HY-179170S	Malonyl CoA-13C3 lithium	Inhibitor	/	Unkown
HY-179863	BODIPY 505/515-C3-CONH-Oleic acid		/	Unkown
HY-180562	KARS-IN-1	Inhibitor	/	Unkown
HY-180971	Ceritinib-amide-C3-acid	Ligand	/	Unkown
HY-180978	H2N-PEG3-C2-Trizole-C3-COOH		/	Unkown
HY-180980	H2N-PEG4-C2-Trizole-C3-COOH		/	Unkown
HY-181040	Factor B-IN-8	Inhibitor	/	Unkown
HY-181062	VWK147		/	Unkown
HY-181542	SG-55		/	Unkown
HY-181918	PLM-101-C3-NHBoc		/	Unkown
HY-182978	Pomalidomide-C3-O-C4-O-C3-NH2		/	Unkown
HY-183352	BuChE-IN-23	Inhibitor	/	Unkown
HY-184526	HOOC-PEG5-N-(C3H7-isopropyl)-NH2		/	Unkown
HY-184537	Desmethyl-QCA276-C3-alkyne		/	Unkown
HY-184699	AKR1C3-IN-16	Inhibitor	/	Unkown
HY-186105	P7C3-S243		/	Unkown
HY-186105A	(-)-P7C3-S243	Inhibitor	/	Unkown
HY-187077	UNC0642-C3-COOH	Ligand	/	Unkown
HY-19657S1	Oxypurinol-13C3,15N3	Inhibitor	/	Unkown
HY-19717S	DCVC-13C3,15N		/	Unkown
HY-21191S	Perfluorobutanesulfonic acid-13C3 sodium		/	Unkown
HY-21196S	Perfluorohexanesulfonic acid-13C3 sodium		/	Unkown
HY-23506S	1-Aminohydantoin-13C3		/	Unkown
HY-32349S3	Ercalcidiol-13C3		/	Unkown
HY-32351B	3-epi-Calcifediol		/	Unkown
HY-40354S1	Tofacitinib-13C3,15N		99.57%	Unkown
HY-42429	CPI-203-PEG1-C3-O-COOH		/	Unkown
HY-A0090S	Nitrofurantoin-13C3	Inhibitor	/	Unkown
HY-A0132S5	N-Acetyl-D-glucosamine-13C-3		/	Unkown
HY-A0132S9	N-Acetyl-D-glucosamine-13C3,15N		/	Unkown
HY-A0253S	Cefacetrile-13C3		/	Unkown
HY-B0143S4	Niacin-15N,13C3		/	Unkown
HY-B0166S4	L-Ascorbic acid-13C-3		/	Unkown
HY-B0388S	Probucol-13C3	Inhibitor	/	Unkown
HY-B0389S18	D-Glucose-13C3-1		/	Unkown
HY-B0495S4	Lamotrigine-13C3		/	Unkown
HY-B0526S	Flumequine-13C3	Inhibitor	/	Unkown
HY-B0636S1	Triamcinolone acetonide-13C3		/	Unkown
HY-B1075AS	(Rac)-Fosfomycin (benzylamine)-13C3		/	Unkown
HY-B1331S1	Cyromazine-13C3		/	Unkown
HY-B1449S4	Uridine-13C-3		/	Unkown
HY-B1659AS	D-Glycerol-13C-3		/	Unkown
HY-B1659S	Glycerol-13C3,d8		/	Unkown
HY-B1890S	(±)-Catechin-13C3	Inhibitor	/	Unkown
HY-B2235S	(Z,Z)-Lecithin-13C3		/	Unkown
HY-CE00612	2'-(5''-Phosphoribosyl)-3'-dephospho-CoA		/	Unkown
HY-CE00614	2'-(5-Triphosphoribosyl)-3'-dephospho-CoA		/	Unkown
HY-D1516	NerveGreen C3		/	Unkown
HY-D1558	1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs		/	Unkown
HY-D2200	Cy5.5(Me)-C3-DBCO		/	Unkown
HY-D3516	5-FAM C3 alkyne		/	Unkown
HY-D3518	Coumarin 343 C3 azide		/	Unkown
HY-E70152	ST6 Sialyltransferase 4		/	Unkown
HY-E71077	(5R)-Carbapenem-3-carboxylate synthase		/	Unkown
HY-N0001S	(±)-Epicatechin-13C3		/	Unkown
HY-N0055S	Chlorogenic acid-13C3		/	Unkown
HY-N0059S3	D-Arabinose-13C-3		/	Unkown
HY-N0060S1	Ferulic acid-13C3	Inhibitor	98.3%	Unkown
HY-N0086S3	N6-Methyladenosine-13C3	Inhibitor	/	Unkown
HY-N0210S2	D-Galactose-13C-3		99.80%	Unkown
HY-N0229S5	L-Alanine-13C3,15N,d4		99.7%	Unkown
HY-N0376R	Liquiritin (Standard)		/	Unkown
HY-N0379S8	D-Mannose-13C-3		/	Unkown
HY-N0382S	Galangin-13C3		/	Unkown
HY-N0521AS	(+)-Gallocatechin-13C3		/	Unkown
HY-N0683S1	2-ambo-Vitamin E-13C3	Inhibitor	/	Unkown
HY-N10263	Palmarumycin C3		/	Unkown
HY-N10519	Cellooctaose		/	Unkown
HY-N10998	Chamaejasmenin A		/	Unkown
HY-N11646	Ganorbiformin B	Inhibitor	/	Unkown
HY-N1480S3	(-)-Fucose-13C-3		/	Unkown
HY-N19814	3'-Deacetylfusicoccin A		/	Unkown
HY-N1981S2	Triolein-13C3-1		/	Unkown
HY-N2362S7	DL-Alanine-13C3-4		/	Unkown
HY-N8847S	α-Ionone-13C3		/	Unkown
HY-P1142S	GLP-2(rat) (Ala-13C3,15N)		/	Unkown
HY-P1142S1	GLP-2(rat) (Ala-13C3,15N) TFA		/	Unkown
HY-P11699	AAPDNRETF		/	Unkown
HY-P11857	Alkyne-GRWHPM-CONH-NH-CMK	Inhibitor	/	Unkown
HY-P11946	C3.15		/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1345B	[DArg10, DAla20] TLQP-21		/	Unkown
HY-P1345C	[DArg10, Aib20] TLQP-21	Antagonist	/	Unkown
HY-P1363S1	β-Amyloid (1-42), human, Ala(13C3,15N) TFA		99.57%	Unkown
HY-P1398A	Compstatin control peptide TFA	Control	/	Unkown
HY-P2830	Complement factor D		/	Unkown
HY-P3204A	POT-4 TFA	Inhibitor	/	Unkown
HY-P5071	EcAMP3		/	Unkown
HY-R00006A	hsa-let-7c-3p agomir		/	Unkown
HY-R00333A	hsa-miR-181c-3p agomir		/	Unkown
HY-R00717A	hsa-miR-34c-3p agomir		/	Unkown
HY-R00832	hsa-miR-374c-3p mimic		/	Unkown
HY-R00832A	hsa-miR-374c-3p agomir		/	Unkown
HY-R00840A	hsa-miR-376c-3p agomir		/	Unkown
HY-R01112A	hsa-miR-449c-3p agomir		/	Unkown
HY-R01546	hsa-miR-513c-3p mimic		/	Unkown
HY-R01546A	hsa-miR-513c-3p agomir		/	Unkown
HY-R01568A	hsa-miR-518c-3p agomir		/	Unkown
HY-R01590	hsa-miR-519c-3p mimic		/	Unkown
HY-R01590A	hsa-miR-519c-3p agomir		/	Unkown
HY-R01598	hsa-miR-520c-3p mimic		/	Unkown
HY-R01598A	hsa-miR-520c-3p agomir		/	Unkown
HY-R01678A	hsa-miR-548c-3p agomir		/	Unkown
HY-R02506	hsa-miR-892c-3p mimic		/	Unkown
HY-R02506A	hsa-miR-892c-3p agomir		/	Unkown
HY-R02698A	mmu-miR-181c-3p agomir		/	Unkown
HY-R02795	mmu-miR-1970c-3p mimic		/	Unkown
HY-R02795A	mmu-miR-1970c-3p agomir		/	Unkown
HY-R02833	mmu-miR-216c-3p mimic		/	Unkown
HY-R02833A	mmu-miR-216c-3p agomir		/	Unkown
HY-R02840	mmu-miR-219c-3p mimic		/	Unkown
HY-R02840A	mmu-miR-219c-3p agomir		/	Unkown
HY-R02897A	mmu-miR-302c-3p agomir		/	Unkown
HY-R03043	mmu-miR-344c-3p mimic		/	Unkown
HY-R03043A	mmu-miR-344c-3p agomir		/	Unkown
HY-R03077	mmu-miR-34c-3p mimic		/	Unkown
HY-R03077A	mmu-miR-34c-3p agomir		/	Unkown
HY-R03104	mmu-miR-374c-3p mimic		/	Unkown
HY-R03104A	mmu-miR-374c-3p agomir		/	Unkown
HY-R03111	mmu-miR-376c-3p mimic		/	Unkown
HY-R03111A	mmu-miR-376c-3p agomir		/	Unkown
HY-R03148	mmu-miR-449c-3p mimic		/	Unkown
HY-R03148A	mmu-miR-449c-3p agomir		/	Unkown
HY-R03198	mmu-miR-467c-3p mimic		/	Unkown
HY-R03198A	mmu-miR-467c-3p agomir		/	Unkown
HY-R03460	mmu-miR-669c-3p mimic		/	Unkown
HY-R03460A	mmu-miR-669c-3p agomir		/	Unkown
HY-R04277	rno-miR-196c-3p mimic		/	Unkown
HY-R04277A	rno-miR-196c-3p agomir		/	Unkown
HY-R04284	rno-miR-200c-3p mimic		/	Unkown
HY-R04284A	rno-miR-200c-3p agomir		/	Unkown
HY-R04468	rno-miR-449c-3p mimic		/	Unkown
HY-R04468A	rno-miR-449c-3p agomir		/	Unkown
HY-R04484	rno-miR-466c-3p mimic		/	Unkown
HY-R04484A	rno-miR-466c-3p agomir		/	Unkown
HY-RI00006	hsa-let-7c-3p inhibitor		/	Unkown
HY-RI00006A	hsa-let-7c-3p antagomir		/	Unkown
HY-RI00333A	hsa-miR-181c-3p antagomir		/	Unkown
HY-RI00407A	hsa-miR-200c-3p antagomir		/	Unkown
HY-RI00717	hsa-miR-34c-3p inhibitor		/	Unkown
HY-RI00717A	hsa-miR-34c-3p antagomir		/	Unkown
HY-RI00832	hsa-miR-374c-3p inhibitor		/	Unkown
HY-RI00832A	hsa-miR-374c-3p antagomir		/	Unkown
HY-RI00840A	hsa-miR-376c-3p antagomir		/	Unkown
HY-RI01112	hsa-miR-449c-3p inhibitor		/	Unkown
HY-RI01112A	hsa-miR-449c-3p antagomir		/	Unkown
HY-RI01546	hsa-miR-513c-3p inhibitor		/	Unkown
HY-RI01546A	hsa-miR-513c-3p antagomir		/	Unkown
HY-RI01568	hsa-miR-518c-3p inhibitor		/	Unkown
HY-RI01568A	hsa-miR-518c-3p antagomir		/	Unkown
HY-RI01590	hsa-miR-519c-3p inhibitor		/	Unkown
HY-RI01590A	hsa-miR-519c-3p antagomir		/	Unkown
HY-RI01598	hsa-miR-520c-3p inhibitor		/	Unkown
HY-RI01598A	hsa-miR-520c-3p antagomir		/	Unkown
HY-RI01678	hsa-miR-548c-3p inhibitor		/	Unkown
HY-RI01678A	hsa-miR-548c-3p antagomir		/	Unkown
HY-RI02506	hsa-miR-892c-3p inhibitor		/	Unkown
HY-RI02506A	hsa-miR-892c-3p antagomir		/	Unkown
HY-RI02698	mmu-miR-181c-3p inhibitor		/	Unkown
HY-RI02698A	mmu-miR-181c-3p antagomir		/	Unkown
HY-RI02795	mmu-miR-1970c-3p inhibitor		/	Unkown
HY-RI02795A	mmu-miR-1970c-3p antagomir		/	Unkown
HY-RI02833	mmu-miR-216c-3p inhibitor		/	Unkown
HY-RI02833A	mmu-miR-216c-3p antagomir		/	Unkown
HY-RI02840	mmu-miR-219c-3p inhibitor		/	Unkown
HY-RI02840A	mmu-miR-219c-3p antagomir		/	Unkown
HY-RI02897	mmu-miR-302c-3p inhibitor		/	Unkown
HY-RI02897A	mmu-miR-302c-3p antagomir		/	Unkown
HY-RI03043	mmu-miR-344c-3p inhibitor		/	Unkown
HY-RI03043A	mmu-miR-344c-3p antagomir		/	Unkown
HY-RI03077	mmu-miR-34c-3p inhibitor		/	Unkown
HY-RI03077A	mmu-miR-34c-3p antagomir		/	Unkown
HY-RI03104	mmu-miR-374c-3p inhibitor		/	Unkown
HY-RI03104A	mmu-miR-374c-3p antagomir		/	Unkown
HY-RI03111	mmu-miR-376c-3p inhibitor		/	Unkown
HY-RI03111A	mmu-miR-376c-3p antagomir		/	Unkown
HY-RI03148	mmu-miR-449c-3p inhibitor		/	Unkown
HY-RI03148A	mmu-miR-449c-3p antagomir		/	Unkown
HY-RI03198	mmu-miR-467c-3p inhibitor		/	Unkown
HY-RI03198A	mmu-miR-467c-3p antagomir		/	Unkown
HY-RI03460	mmu-miR-669c-3p inhibitor		/	Unkown
HY-RI03460A	mmu-miR-669c-3p antagomir		/	Unkown
HY-RI04277	rno-miR-196c-3p inhibitor		/	Unkown
HY-RI04277A	rno-miR-196c-3p antagomir		/	Unkown
HY-RI04284	rno-miR-200c-3p inhibitor		/	Unkown
HY-RI04284A	rno-miR-200c-3p antagomir		/	Unkown
HY-RI04468	rno-miR-449c-3p inhibitor		/	Unkown
HY-RI04468A	rno-miR-449c-3p antagomir		/	Unkown
HY-RI04484	rno-miR-466c-3p inhibitor		/	Unkown
HY-RI04484A	rno-miR-466c-3p antagomir		/	Unkown
HY-RS00536	AKR1C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05969	H3C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS05976	H4C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10520	PIK3C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS10522	Pik3c3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W007798S	Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N		98.7%	Unkown
HY-W007926S	2-Oxobutanoic acid-13C,d2-1		/	Unkown
HY-W009204S4	Fmoc-Ala-OH-13C3,15N		99.9%	Unkown
HY-W010407S2	Cyanuric acid-13C3,15N3		/	Unkown
HY-W010575S	(2R)-3-Amino-2-fluoropropanoic acid-13C3		/	Unkown
HY-W010596S	Malonamide-13C3		/	Unkown
HY-W013061S11	Tripalmitin (Glycerol 13C3,13C 99%)		/	Unkown
HY-W013061S4	Propane-1,2,3-triyl tripalmitate-13C3-1		/	Unkown
HY-W015084S	β-Ionone-13C3	Inducer	/	Unkown
HY-W017529S	6-Chloro-1,3,5-triazine-2,4-diamine-13C3		/	Unkown
HY-W017540S	Cyclocreatine-13C3		/	Unkown
HY-W018772S4	D-Ribose-13C-3		99.9%	Unkown
HY-W096151	Chloroacetamido-C-PEG3-C3-NHBoc		/	Unkown
HY-W127393	N-Nonanoyl-L-homoserine lactone		/	Unkown
HY-W127487	N-Octadecanoyl-L-homoserine lactone		/	Unkown
HY-W269693S	5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-13C3,d5		/	Unkown
HY-W324220	11β-HSD1-IN-10		/	Unkown
HY-W357090S	L-Idose-13C-3		/	Unkown
HY-W456457	Tetrapyrido[3,2-a:2',3'-c:3'',2''-h:2''',3'''-j]phenazine		/	Unkown
HY-W584535	VH032-C3-Boc		/	Unkown
HY-W585905	Trimethylammonium chloride-13C3	Inhibitor	/	Unkown
HY-W591717	EM-12-alkyne-C3-NH2		/	Unkown
HY-W653931	rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C3		/	Unkown
HY-W653989	Desonide-13C3		/	Unkown
HY-W654296	Octocrylene-13C3		/	Unkown
HY-W706737	N-Deschlorobenzoyl indomethacin-d3		/	Unkown
HY-W718035S	1-Chloro-3-(octanoyloxy)propan-2-yl decanoate-13C3		/	Unkown
HY-W718041S	1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3		/	Unkown
HY-W747791	4,6-Dichloro-1,3,5-triazin-2-amine-13C3		/	Unkown
HY-W748430	Furagin-13C3		/	Unkown
HY-W748519	Sarcosine-13C3		/	Unkown
HY-W749145	2-Chloro-5-thiazolecarboxylic Acid-13C3,15N		/	Unkown
HY-W749394	4-Methyl-5-thiazoleethanol-13C3		/	Unkown
HY-W749519	(E,E)-Farnesol-13C3		/	Unkown
HY-W749742	Isopropyltriphenylphosphonium bromide-13C3		/	Unkown
HY-W749783	1-Decanoyl-2-octanoyl-3-chloropropanediol-13C3		/	Unkown
HY-W749786	1-Decanoyl-2-lauroyl-3-chloropropanediol-13C3		/	Unkown
HY-W750553	2-Ethylhexyl 2-cyanoacetate-13C3		/	Unkown
HY-W751156	O-Phospho-L-serine-13C3		/	Unkown
HY-W751753	Ethyl (2-cyanoacetyl)carbamate-13C3,15N		/	Unkown
HY-W751756	6-Cyano Diclazuril-13C3,15N2		/	Unkown
HY-W751808S	2,3-Diphosphoglyceric acid-13C3		/	Unkown
HY-W751832	5,6-Diaminopyrimidine-2,4-diol hydrochloride-13C3		/	Unkown
HY-W751834	6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3		/	Unkown
HY-W753497	Benzene-1,2,4-tricarboxylic acid-13C3		/	Unkown
HY-W754236	(R)-Carnitine Hydrochloride-13C3		/	Unkown
HY-W756586	Rac 2-stearoyl-3-chloropropanediol-13C3		/	Unkown
HY-W756589	Rac 2-linolenoyl-3-chloropropanediol-13C3		/	Unkown
HY-W759219	Adrenosterone-13C3		/	Unkown
HY-W759459	Meldrum's acid-13C3		/	Unkown
HY-W765177	Acetyl-L-carnitine hydrochloride-13C3		/	Unkown
HY-W766603	Thiouric Acid Sodium Salt Dihydrate-13C3		/	Unkown
HY-W768226	D-Fructose-1,2,3-13C3		/	Unkown
HY-W768527	Methyl piperidine-4-carboxylate hydrochloride-13C3		/	Unkown
HY-W768964	a,a-Dimethyl-1H-indole-2-acetonitrile-13C315N		/	Unkown
HY-W768990	Vinclozolin-13C3,d3		/	Unkown
HY-W769556	Ethyl Cyano(ethoxymethylene)acetate-13C3		/	Unkown
HY-W770279	DL-Cytarabine-13C3		/	Unkown
HY-W770914	Stearoyl-L-carnitine chloride-13C3		/	Unkown
HY-W776973	Glycidamide-13C3		/	Unkown
HY-W777002	Famotidine-13C3		/	Unkown
HY-W777084	(E)-3,4-Dimethoxycinnamic acid-13C3		/	Unkown
HY-W777266	Cyclohexane-1,3-dione-13C3		/	Unkown
HY-W777281	Fluocinolone acetonide-13C3		/	Unkown
HY-W777340	Gimeracil-13C3		/	Unkown
HY-W777351	Etravirine-13C3		/	Unkown
HY-W777615	Ammeline Hydrochloride-13C3		/	Unkown
HY-W777751	6-Desamino 6-chloro etravirine-13C3		/	Unkown
HY-W777806	Pyrimido[1,2-a]purin-10(1H)-one-13C3		/	Unkown
HY-W777836	2,2-Dibromomalonamide-13C3		/	Unkown
HY-W777862	1-Stearoyl-rac-glycerol-13C3,d5		/	Unkown
HY-W778057	Ethyl 3,4-Dihydroxybenzoate-13C3		/	Unkown
HY-W778286	Enterolactone-13C3		/	Unkown
HY-W778288	(±)-Enterodiol-13C3		/	Unkown
HY-W778511	Levulinic acid-13C3		/	Unkown
HY-W778954	2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3		/	Unkown
HY-W779236	Ethyl Propargylate-13C3		/	Unkown
HY-W946627	(S,R,S)-AHPC-Me-amide-C-O-C3-PEG1-NH2		/	Unkown
HY-Y0418S3	Dulcite-13C-3		/	Unkown
HY-Y0504S	Trimethylammonium chloride-13c3,d9	Inhibitor	98%	Unkown
HY-Y0659S1	1,2,3,4-Hydroquinoline-13C3,15N		/	Unkown
HY-Y0921S3	(±)-1,2-Propanediol-13C3		/	Unkown
HY-Y1117S1	Melamine-13C3		98.71%	Unkown
HY-10002S	Calcitriol-13C3	Inhibitor	97.0%	Unkown
HY-100840	(S)-4C3HPG		/	Unkown
HY-100840A	(RS)-4C3HPG	Antagonist	/	Unkown
HY-112251S	D-Lin-MC3-DMA-13C3		/	Unkown
HY-115767S	(±)-1,2-Diolein-13C3	Activator	/	Unkown
HY-122585	proMMP-9 inhibitor-3c	Inhibitor	/	Unkown
HY-124432	CRT0093964	Inhibitor	/	Unkown
HY-125485	Fmoc-C-PEG3-C3-Succinamic acid		/	Unkown
HY-127035S1	Tristearin-13C3		/	Unkown
HY-137225	HTS07944		/	Unkown
HY-139227	Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride	Inducer	/	Unkown
HY-144344S	Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3		/	Unkown
HY-148637	Picoberin	Agonist	/	Unkown
HY-149749	Methylthiomcresol-C3-COOH		/	Unkown
HY-150532S	(Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N		/	Unkown
HY-154746S	3-HPMA Potassium Salt-3-13C3,15N		/	Unkown
HY-154814S	Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium		/	Unkown
HY-159145	Lenalidomide-acetylene-C3-MsO		/	Unkown
HY-161652	Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	Unkown
HY-161656	PIP-C-3-Azaspiro[5.5]undecane-boc		/	Unkown
HY-163267	ZNL0325		/	Unkown
HY-163647	Lenalidomide-COCH-PEG2-azido		/	Unkown
HY-165686	Benalaxyl metabolite M2-13C3		/	Unkown
HY-168192	Thalidomide-NH-C4-amide-C3-Br		/	Unkown
HY-168380	Lipid C3		/	Unkown
HY-172223	3-Deazaguanosine	Inhibitor	/	Unkown
HY-172296	Biotinamide-C3-PEG3-C-alkyne		/	Unkown
HY-173103S	FYDPL(Ala-13C3,15N)GK TFA		/	Unkown
HY-17469S	Gimeracil-13C3,15N		/	Unkown
HY-175506	RyRs activator 6		/	Unkown
HY-175948	Lenalidomide-CO-C3-NH-alkynes		/	Unkown
HY-176038	MS1262-C3-amide-C10-amine		/	Unkown
HY-176893	Mm-C3-OSu		/	Unkown
HY-177148B	(E/Z)-G256 dihydrochloride	Substrate	/	Unkown
HY-180767	Azithromycin-amide-C3-amide-quinoxaline	Inhibitor	/	Unkown
HY-182222	5'-Amino-modifier C3-TFA		/	Unkown
HY-186237	Fuc(1→2)-Gal(3→1)(C3-amide-C5-biotin)-GalNAc		/	Unkown
HY-41700S5	D-Alanine-13C3		/	Unkown
HY-B0111RS	Drospirenone-13C3		/	Unkown
HY-B0399S2	L-Carnitine-13C3		/	Unkown
HY-B0510S3	Trimethoprim-13C3	Inhibitor	/	Unkown
HY-D0205AS1	Carbocisteine-13C3-1		/	Unkown
HY-N0001S2	(-)-Epicatechin-13C3		/	Unkown
HY-N0092S4	Inosine-13C3	Agonist	/	Unkown
HY-N0230S5	β-Alanine-13C		/	Unkown
HY-N0368S1	Linalool-13C3		/	Unkown
HY-N0803S1	Myrcene-13C3	Inhibitor	/	Unkown
HY-N1071	Wilforol C		/	Unkown
HY-N12816	Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside		/	Unkown
HY-N14052	Arizonin C3	Inhibitor	/	Unkown
HY-N14105	Cinatrin C3	Inhibitor	/	Unkown
HY-N14419	Salfredin C3	Inhibitor	/	Unkown
HY-N14460	Pluracidomycin C3	Inhibitor	/	Unkown
HY-N14691	Platenomycin C3	Inhibitor	/	Unkown
HY-N1849	3'-Methoxyrocaglamide		/	Unkown
HY-N5181	Parvodicin C3	Inhibitor	/	Unkown
HY-N7091S1	Atrazine-13C3,15N3		/	Unkown
HY-N7092S22	D-Fructose-13C3		/	Unkown
HY-N7092S23	D-Fructose-13C3-1		/	Unkown
HY-N9332	Kalopanax saponin G		/	Unkown
HY-N9522	β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate		99.95%	Unkown
HY-P0058S	Pramlintide-(Ala-13C3,15N)		/	Unkown
HY-P1624S	Teduglutide-Ala(13C3,15N) sodium		/	Unkown
HY-P6696S	β-CL, Ala(13C3,15N) TFA		/	Unkown
HY-R04628	mmu-miR-200c-3p mimic		/	Unkown
HY-RI04615	mmu-miR-200c-3p inhibitor		/	Unkown
HY-RS16401	NT5C3A Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS16520	C3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS22951	C3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS23044	Akr1c3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS27683	Nt5c3a Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS28019	C3ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W007941S	Fmoc-Ser(tBu)-OH-13C3,15N		99.5%	Unkown
HY-W009204S5	Fmoc-Ala-OH-13C3	Modulator	98.5%	Unkown
HY-W012578S1	2-Isopropyl-3-methoxypyrazine-13C3		/	Unkown
HY-W012932S	2,4-Dimethylthiazole-13C3		/	Unkown
HY-W020044S	DL-alpha-Tocopherol-13C3	Inhibitor	/	Unkown
HY-W021040S	Fludioxonil-13C3		/	Unkown
HY-W091039S	N-Acetyl-α-neuraminic acid-13C3		/	Unkown
HY-W1110947	(S)-3-Phosphoglyceric acid-13C3 sodium		/	Unkown
HY-W1113139	H2N-PEG4-C3-OH		/	Unkown
HY-W115358	Piperazin-C3-OH dihydrochloride		/	Unkown
HY-W128657S	3-Chloro-2-hydroxypropanoic acid-13C3		/	Unkown
HY-W130878	4-Octylphenol	Activator	/	Unkown
HY-W156840S	OTNE-13C3		/	Unkown
HY-W190925	APN-C3-biotin		/	Unkown
HY-W339437	NH2-C3-PEG2-NH2		/	Unkown
HY-W440913	DSPE-PEG5000-Cy5		/	Unkown
HY-W585819S	3-Chloropropane-1,2-diol dipalmitate-13C3		/	Unkown
HY-W653853	Ritonavir-13C3		/	Unkown
HY-W654120	Creatine-13C3		/	Unkown
HY-W654126	Cytarabine-13C3		/	Unkown
HY-W654127	Cytarabine-13C3 5'-monophosphate		/	Unkown
HY-W654156	Diclazuril-13C3,15N2	Inhibitor	/	Unkown
HY-W654362	(R)-2-Thioxothiazolidine-4-carboxylic acid-13C3		/	Unkown
HY-W743781	N-Nitrosonornicotine-d4		/	Unkown
HY-W747639	Glycidyl Stearate-13C3		/	Unkown
HY-W748200	3-Hydroxypropionic acid-13C3 sodium		/	Unkown
HY-W749516	Voglibose-13C3	Inhibitor	/	Unkown
HY-W749756	rac-1,2-Distearoyl-3-chloropropanediol-13C3		/	Unkown
HY-W751098	Aldosterone-13C3		/	Unkown
HY-W751099	Corticosterone-13C3		/	Unkown
HY-W767866	N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 dicyclohexylamine		/	Unkown
HY-W769714	Favipiravir-13C3	Inhibitor	/	Unkown
HY-W770183	Uric acid-13C3		/	Unkown
HY-W777148	Anagrelide-13C3		/	Unkown
HY-W923498	Boc-NH-C3-O-Propargyl		/	Unkown
HY-W998285	Pomalidomide-C3-alkyne		/	Unkown
HY-W998298	(S,R,S)-AHPC-C5-PEG3-C3		/	Unkown
HY-W998312	Thalidomide-O-amido-C3-COOH TFA		/	Unkown
HY-W998315	(S,R,S)-AHPC-Me-CO-C3-COOH		/	Unkown
HY-W998328	Thalidomide-O-amido-C3-NH2 hydrochloride		/	Unkown
HY-109506S10	DPPC-13C3		/	Unkown
HY-P3252AS	Pegcetacoplan-13C3,15N TFA		/	Unkown

Inhibitory Antibodies (7)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P990216	Anti-Mouse IL-25 Antibody (2C3)	Inhibitor	95.00%	Unkown
HY-P991706	Nelvutamig	Inhibitor	97.76%	Unkown
HY-P990955	Ebribafusp alfa	Inhibitor	96.40%	Unkown
HY-P992456	SAR-443809	Inhibitor	/	Unkown
HY-P991590	1D09C3		/	Unkown
HY-P991936	Anti-CEACAM5/CEA/CD66e Antibody (16C3)		/	Unkown
HY-P992470	STT-5058	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Macaca mulatta	C3	VGNC	VGNC:108484
Mus musculus	C3	MGD	MGI:88227
Rattus norvegicus	C3	RGD	RGD:2232
Bos taurus	C3	VGNC	VGNC:26638
Canis familiaris	C3	VGNC	VGNC:38591
Others	C3	NCBI